China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the correlation between anlotinib concentration and efficacy and adverse reacti... Read More
China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Investigation on the Occurrence of Spontaneous Hypothermia after Emergency Trauma and Co... Read More
China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effect of remimazolam on gastrointestinal function recovery after general anesthesia... Read More
China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective observational clinical study on the safety and efficacy of Auckland tourni... Read More
China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An Individualized Perioperative Discontinuation Strategy for GLP-1 Receptor Agonists: A ... Read More
China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of resilience on food addiction among patients with type 2 diabetes: the mediatin... Read More
China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinicopathological Characteristics of Mixed Gangliocytoma-Pituitary Neuroendocrine Tumo... Read More
China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on dynamic trajectory model of breast milk microflora participating in growth and ... Read More
China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The role of biliary stent placement in managing recurrent common bile duct stones and ad... Read More
China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety Evaluation of MHA Revival (0.2%) Firming and Anti-Wrinkle Cream: A R... Read More